Type I IFN signaling facilitates the development of IL-10-producing effector CD8+ T cells during murine influenza virus infection

European Journal of Immunology

Volumn 46, Issue 12, 2016, Pages 2778-2788

  Jiang, Li ^a   Yao, Shuyu ^a   Huang, Su ^a   Wright, Jeffrey ^b   Braciale, Thomas J ^b   Sun, Jie ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

CD8+ T cells; IL 10; IL 27; Influenza; Type I IFN

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; INTERFERON; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 27; ALPHA BETA INTERFERON RECEPTOR; IFNAR1 PROTEIN, MOUSE; STAT2 PROTEIN; STAT2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLUENZA; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL CULTURE; DENDRITIC CELL; GENETICS; HUMAN; IMMUNOLOGY; LUNG; LYMPHOCYTE ACTIVATION; METABOLISM; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; INFLUENZA, HUMAN; INTERFERON TYPE I; INTERLEUKIN-10; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; STAT2 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

EID: 85000910610     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646548     Document Type: Article

References (44)

1. Zhang, N. and Bevan, M. J., CD8(+) T cells: foot soldiers of the immune system. Immunity 2011. 35: 161–168.
2. Braciale, T. J., Sun, J. and Kim, T. S., Regulating the adaptive immune response to respiratory virus infection. Nat. Rev. Immunol. 2012. 12: 295–305.
3. Kim, T. S., Sun, J. and Braciale, T. J., T cell responses during influenza infection: getting and keeping control. Trends Immunol. 2011. 32: 225–231.
4. Hufford, M. M., Kim, T. S., Sun, J. and Braciale, T. J., The effector T cell response to influenza infection. Curr. Top Microbiol. Immunol. 2015. 386: 423–455.
5. Sun, J. and Braciale, T. J., Role of T cell immunity in recovery from influenza virus infection. Curr. Opin. Virol. 2013. 3: 425–429.
6. + T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat. Immunol. 2011. 12: 327–334.
7. Sun, J., Cardani, A., Sharma, A. K., Laubach, V. E., Jack, R. S., Muller, W. and Braciale, T. J., Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog. 2011. 7: e1002173.
8. Sun, J., Madan, R., Karp, C. L. and Braciale, T. J., Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 2009. 15: 277–284.
9. Trandem, K., Zhao, J., Fleming, E. and Perlman, S., Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J. Immunol. 2011. 186: 3642–3652.
10. Loebbermann, J., Schnoeller, C., Thornton, H., Durant, L., Sweeney, N. P., Schuijs, M., O'Garra, A. et al., IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS One 2012. 7: e32371.
11. + effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment. Virology 2010. 404: 225–230.
12. Stevens, W. W., Sun, J., Castillo, J. P. and Braciale, T. J., Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease. Viral Immunol. 2009. 22: 243–251.
13. Mescher, M. F., Curtsinger, J. M., Agarwal, P., Casey, K. A., Gerner, M., Hammerbeck, C. D., Popescu, F. et al., Signals required for programming effector and memory development by CD8+ T cells. Immunol. Rev. 2006. 211: 81–92.
14. + T cells. Front Immunol. 2014. 5: 295.
15. + T cells from NK cell cytotoxicity. Immunity 2014. 40: 949–960.
16. Crouse, J., Bedenikovic, G., Wiesel, M., Ibberson, M., Xenarios, I., Von Laer, D., Kalinke, U. Vivier, E., Jonjic, S. and Oxenius, A., Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity 2014. 40: 961–973.
17. Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J. et al., Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 2013. 340: 202–207.
18. Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C., Welch, M., Schreiber, R. D. et al., Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 2013. 340: 207–211.
19. Arimori, Y., Nakamura, R., Yamada, H., Shibata, K., Maeda, N., Kase, T. and Yoshikai, Y., Type I interferon plays opposing roles in cytotoxicity and interferon-gamma production by natural killer and CD8 T cells after influenza A virus infection in mice. J. Innate Immun. 2014. 6: 456–466.
20. Arimori, Y., Nakamura, R., Yamada, H., Shibata, K., Maeda, N., Kase, T. and Yoshikai, Y., Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice. Antiviral Res. 2013. 99: 230–237.
21. + T cells with cytotoxic potential during influenza virus infection. J. Virol. 2013. 87: 11884–11893.
22. Sun, J. and Pearce, E. J., Suppression of early IL-4 production underlies the failure of CD4 T cells activated by TLR-stimulated dendritic cells to differentiate into Th2 cells. J. Immunol. 2007. 178: 1635–1644.
23. Park, C., Li, S., Cha, E. and Schindler, C., Immune response in Stat2 knockout mice. Immunity 2000. 13: 795–804.
24. Ivashkiv, L. B. and Donlin, L. T., Regulation of type I interferon responses. Nat. Rev. Immunol. 2014. 14: 36–49.
25. Madan, R., Demircik, F., Surianarayanan, S., Allen, J. L., Divanovic, S., Trompette, A., Yogev, N. et al., Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 2009. 183: 2312–2320.
26. Iyer, S. S., Ghaffari, A. A. and Cheng, G., Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J. Immunol. 2010. 185: 6599–6607.
27. Hufford, M. M., Richardson, G., Zhou, H., Manicassamy, B., Garcia-Sastre, A., Enelow, R. I. and Braciale, T. J., Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells. PLoS One 2012. 7: e46581.
28. + T cell effector activities in situ are regulated by target cell type. J. Exp. Med. 2011. 208: 167–180.
29. Yao, S., Buzo, B. F., Pham, D., Jiang, L., Taparowsky, E. J., Kaplan, M. H. and Sun, J., Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. Immunity 2013. 39: 833–845.
30. Ahyi, A. N., Chang, H. C., Dent, A. L., Nutt, S. L. and Kaplan, M. H., IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J. Immunol. 2009. 183: 1598–1606.
31. Cretney, E., Xin, A., Shi, W., Minnich, M., Masson, F., Miasari, M., Belz, G. T. et al., The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 2011. 12: 304–311.
32. McNab, F., Mayer-Barber, K., Sher, A., Wack, A. and O'Garra, A., Type I interferons in infectious disease. Nat. Rev. Immunol. 2015. 15: 87–103.
33. Garcia-Sastre, A., Induction and evasion of type I interferon responses by influenza viruses. Virus Res. 2011. 162: 12–18.
34. Moltedo, B., Lopez, C. B., Pazos, M., Becker, M. I., Hermesh, T. and Moran, T. M., Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J. Immunol. 2009. 183: 3569–3573.
35. Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E. et al., Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011. 146: 980–991.
36. Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y. et al., Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007. 445: 319–323.
37. Hogner, K., Wolff, T., Pleschka, S., Plog, S., Gruber, A. D., Kalinke, U., Walmrath, H. D. et al., Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 2013. 9: e1003188.
38. Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K. and Perlman, S., Dysregulated type i interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 2016. 19: 181–193.
39. Sun, K., Torres, L. and Metzger, D. W., A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J. Virol. 2010. 84: 5007–5014.
40. McKinstry, K. K., Strutt, T. M., Buck, A., Curtis, J. D., Dibble, J. P., Huston, G., Tighe, M. et al., IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J. Immunol. 2009. 182: 7353–7363.
41. Dutta, A., Huang, C. T., Chen, T. C., Lin, C. Y., Chiu, C. H., Lin, Y. C., Chang, C. S. et al., IL-10 inhibits neuraminidase-activated TGF-beta and facilitates Th1 phenotype during early phase of infection. Nat. Commun. 2015. 6: 6374.
42. Oshansky, C. M., Gartland, A. J., Wong, S. S., Jeevan, T., Wang, D., Roddam, P. L., Caniza, M. A. et al., Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am. J. Respir. Crit. Care Med. 2014. 189: 449–462.
43. Starbeck-Miller, G. R., Xue, H. H. and Harty, J. T., IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. J. Exp. Med. 2014. 211: 105–120.
44. Saraiva, M., Christensen, J. R., Veldhoen, M., Murphy, T. L., Murphy, K. M. and O'Garra, A., Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009. 31: 209–219.